81 FR 1194 - Meeting of the National Vaccine Advisory Committee

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 81, Issue 6 (January 11, 2016)

Page Range		1194-1195
FR Document		2016-00319

As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting February 2-3, 2016. The meeting is open to the public. However, pre- registration is required for both public attendance and public comment. Individuals who wish to attend the meeting and/or participate in the public comment session should register at http://www.hhs.gov/nvpo/nvac/ meetings/upcomingmeetings/. Participants may also register by emailing [email protected] or by calling 202-690-5566 and providing their name, organization, and email address.

Federal Register, Volume 81 Issue 6 (Monday, January 11, 2016)

[Federal Register Volume 81, Number 6 (Monday, January 11, 2016)]
[Notices]
[Pages 1194-1195]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-00319]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: National Vaccine Program Office, Office of the Assistant 
Secretary for Health, Office of the Secretary, Department of Health and 
Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a meeting 
February 2-3, 2016. The meeting is open to the public. However, pre-
registration is required for both public attendance and public comment. 
Individuals who wish to attend the meeting and/or participate in the 
public comment session should register at http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/. Participants may also register by emailing 
[email protected] or by calling 202-690-5566 and providing their name, 
organization, and email address.

DATES: The meeting will be held on February 2-3, 2016. The meeting 
times and agenda will be posted on the NVAC Web site at http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/ as soon as they become 
available.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, the Great Hall, 200 Independence Avenue SW., 
Washington, DC 20201.
    The meeting can also be accessed through a live webcast the day of 
the meeting. For more information, visit http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/index.html.

FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. 
Department of Health and Human Services, Room 715-H, Hubert H. Humphrey 
Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: 
(202) 690-5566; email: [email protected].

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The NVAC was established to provide advice and 
make recommendations to the Director of the National Vaccine Program on 
matters related to the Program's responsibilities. The Assistant 
Secretary for Health serves as Director of the National Vaccine 
Program.
    The February 2016 NVAC meeting agenda will include discussions on 
mechanisms to support vaccine development and innovation, vaccine 
pricing and purchasing behaviors in the private vaccine market, and 
quality measures for adult immunizations. The NVAC will hear an update 
on progress towards a mid-course review of the 2010 National Vaccine 
Plan, as well as an update from the NVAC Maternal Immunizations Working 
Group. Committee members also will be provided information on ongoing 
Departmental efforts to support the pre-departure vaccination of U.S.-
bound refugees. Please note that agenda items are subject to change as 
priorities dictate. Information on the final meeting agenda will be 
posted prior to the meeting on the NVAC Web site: http://www.hhs.gov/nvpo/nvac.
    Public attendance at the meeting is limited to the available space. 
Individuals who plan to attend in person and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify the National Vaccine Program Office at 
the address/phone listed above at least one week prior to the meeting. 
For those unable to attend in person, a live webcast will be available. 
More information on registration and accessing the webcast can be found 
at http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/.
    Members of the public will have the opportunity to provide comments 
at the NVAC meeting during the public comment periods designated on the 
agenda. Public comments made during the meeting will be limited to 
three minutes per person to ensure time is allotted for all those 
wishing to speak. Individuals are also welcome to submit their written 
comments. Written comments should not exceed three pages in length. It 
is requested that individuals submitting written comments email their 
comments to the National Vaccine Program Office ([email protected]) at least 
five business days prior to the meeting.


[[Page 1195]]


    Dated: January 5, 2016.
Bruce Gellin,
Executive Secretary, National Vaccine Advisory Committee, Deputy 
Assistant Secretary for Health, Director, National Vaccine Program 
Office.
[FR Doc. 2016-00319 Filed 1-8-16; 8:45 am]
 BILLING CODE 4150-44-P

1194 Federal Register / Vol. 81, No. 6 / Monday, January 11, 2016 / Notices

methodology. The meeting is open to DEPARTMENT OF HEALTH AND recommendations to the Director of the
the public, but attendance is limited to HUMAN SERVICES National Vaccine Program on matters
the space available. There are related to the Program’s responsibilities.
capabilities for remote access. Persons Meeting of the National Vaccine The Assistant Secretary for Health
wishing to attend this meeting must Advisory Committee serves as Director of the National
register by the date listed in the DATES AGENCY: National Vaccine Program Vaccine Program.
section, and register using the Office, Office of the Assistant Secretary The February 2016 NVAC meeting
information in the ‘‘REGISTRATION’’ for Health, Office of the Secretary,
section. agenda will include discussions on
Department of Health and Human mechanisms to support vaccine
III. Security, Building, and Parking Services. development and innovation, vaccine
Guidelines ACTION: Notice. pricing and purchasing behaviors in the
The meeting is open to the public, but SUMMARY: As stipulated by the Federal private vaccine market, and quality
attendance is limited to the space Advisory Committee Act, the measures for adult immunizations. The
available. Persons wishing to attend this Department of Health and Human NVAC will hear an update on progress
meeting must register by using the Services (HHS) is hereby giving notice towards a mid-course review of the 2010
instructions in the ‘‘REGISTRATION’’ that the National Vaccine Advisory National Vaccine Plan, as well as an
section of this notice by the date Committee (NVAC) will hold a meeting update from the NVAC Maternal
specified in the DATES section of this February 2–3, 2016. The meeting is Immunizations Working Group.
notice. open to the public. However, pre- Committee members also will be
This meeting will be held in a Federal
registration is required for both public provided information on ongoing
government building; therefore, Federal
attendance and public comment. Departmental efforts to support the pre-
security measures are applicable. We
Individuals who wish to attend the departure vaccination of U.S.-bound
recommend that confirmed registrants
meeting and/or participate in the public refugees. Please note that agenda items
arrive reasonably early, but no earlier
comment session should register at are subject to change as priorities
than 45 minutes prior to the start of the
http://www.hhs.gov/nvpo/nvac/ dictate. Information on the final meeting
meeting, to allow additional time to
clear security. Security measures meetings/upcomingmeetings/. agenda will be posted prior to the
include the following: Participants may also register by meeting on the NVAC Web site: http://
• Presentation of government-issued emailing nvpo@hhs.gov or by calling www.hhs.gov/nvpo/nvac.
photographic identification to the 202–690–5566 and providing their
name, organization, and email address. Public attendance at the meeting is
Federal Protective Service or Guard limited to the available space.
Service personnel. DATES: The meeting will be held on
• Inspection of vehicle’s interior and February 2–3, 2016. The meeting times Individuals who plan to attend in
exterior (this includes engine and trunk and agenda will be posted on the NVAC person and need special assistance,
inspection) at the entrance to the Web site at http://www.hhs.gov/nvpo/ such as sign language interpretation or
grounds. Parking permits and nvac/meetings/upcomingmeetings/ as other reasonable accommodations,
instructions will be issued after the soon as they become available. should notify the National Vaccine
vehicle inspection. ADDRESSES: U.S. Department of Health Program Office at the address/phone
• Inspection, via metal detector or and Human Services, Hubert H. listed above at least one week prior to
other applicable means of all persons Humphrey Building, the Great Hall, 200 the meeting. For those unable to attend
brought entering the building. We note Independence Avenue SW., in person, a live webcast will be
that all items brought into CMS, Washington, DC 20201. available. More information on
whether personal or for the purpose of The meeting can also be accessed registration and accessing the webcast
presentation or to support a through a live webcast the day of the can be found at http://www.hhs.gov/
presentation, are subject to inspection. meeting. For more information, visit
nvpo/nvac/meetings/
We cannot assume responsibility for http://www.hhs.gov/nvpo/nvac/
upcomingmeetings/.
coordinating the receipt, transfer, meetings/upcomingmeetings/
transport, storage, set-up, safety, or index.html. Members of the public will have the
timely arrival of any personal FOR FURTHER INFORMATION CONTACT: opportunity to provide comments at the
belongings or items used for National Vaccine Program Office, U.S. NVAC meeting during the public
presentation or to support a Department of Health and Human comment periods designated on the
presentation. Services, Room 715–H, Hubert H. agenda. Public comments made during
Note: Individuals who are not registered in Humphrey Building, 200 Independence the meeting will be limited to three
advance will not be permitted to enter the Avenue SW., Washington, DC 20201. minutes per person to ensure time is
building and will be unable to attend the Phone: (202) 690–5566; email: allotted for all those wishing to speak.
meeting. The public may not enter the nvpo@hhs.gov. Individuals are also welcome to submit
building earlier than 45 minutes prior to the
convening of the meeting. SUPPLEMENTARY INFORMATION: Pursuant their written comments. Written
to Section 2101 of the Public Health comments should not exceed three
All visitors must be escorted in areas pages in length. It is requested that
Service Act (42 U.S.C. 300aa–1), the
other than the lower and first floor individuals submitting written
Secretary of Health and Human Services
levels in the Central Building. comments email their comments to the
was mandated to establish the National
Dated: January 4, 2016. Vaccine Program to achieve optimal National Vaccine Program Office
ebenthall on DSK6SPTVN1PROD with NOTICES

Andrew Slavitt, prevention of human infectious diseases (nvpo@hhs.gov) at least five business
Acting Administrator, Centers for Medicare through immunization and to achieve days prior to the meeting.
& Medicaid Services. optimal prevention against adverse
[FR Doc. 2016–00219 Filed 1–8–16; 8:45 am] reactions to vaccines. The NVAC was
BILLING CODE 4120–01–P established to provide advice and make

VerDate Sep<11>2014 21:33 Jan 14, 2016 Jkt 238001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 E:\FR\FM\11JAN1.SGM 11JAN1

Federal Register / Vol. 81, No. 6 / Monday, January 11, 2016 / Notices 1195

Dated: January 5, 2016. DEPARTMENT OF HEALTH AND inspected before being allowed on
Bruce Gellin, HUMAN SERVICES campus. Visitors will be asked to show
Executive Secretary, National Vaccine one form of identification (for example,
Advisory Committee, Deputy Assistant National Institutes of Health a government-issued photo ID, driver’s
Secretary for Health, Director, National license, or passport) and to state the
Vaccine Program Office. National Heart, Lung, and Blood purpose of their visit.
Institute: Notice of Meeting Information is also available on the
[FR Doc. 2016–00319 Filed 1–8–16; 8:45 am]
BILLING CODE 4150–44–P Pursuant to section 10(d) of the Institute’s/Center’s home page:
Federal Advisory Committee Act, as www.nhlbi.nih.gov/meetings/nhlbac/
amended (5 U.S.C. App.), notice is index.htm, where an agenda and any
DEPARTMENT OF HEALTH AND hereby given of a meeting of the additional information for the meeting
HUMAN SERVICES National Heart, Lung, and Blood will be posted when available.
Advisory Council. (Catalogue of Federal Domestic Assistance
National Institutes of Health The meeting will be open to the Program Nos. 93.233, National Center for
public as indicated below, with Sleep Disorders Research; 93.837, Heart and
National Heart, Lung, and Blood Vascular Diseases Research; 93.838, Lung
attendance limited to space available. Diseases Research; 93.839, Blood Diseases
Institute: Notice of Closed Meeting Individuals who plan to attend and and Resources Research, National Institutes
need special assistance, such as sign of Health, HHS)
Pursuant to section 10(d) of the language interpretation or other
Federal Advisory Committee Act, as Dated: January 5, 2016.
reasonable accommodations, should
amended (5 U.S.C. App.), notice is Michelle Trout,
notify the Contact Person listed below
hereby given of the following meeting. in advance of the meeting. Program Analyst, Office of Federal Advisory
Committee Policy.
The meeting will be closed to the The meeting will be closed to the
[FR Doc. 2016–00208 Filed 1–8–16; 8:45 am]
public in accordance with the public in accordance with the
provisions set forth in sections BILLING CODE 4140–01–P
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C., 552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and as amended. The grant applications and
DEPARTMENT OF HEALTH AND
the discussions could disclose the discussions could disclose
HUMAN SERVICES
confidential trade secrets or commercial confidential trade secrets or commercial
property such as patentable material, National Institutes of Health
property such as patentable material,
and personal information concerning
and personal information concerning
individuals associated with the grant National Institute of Neurological
individuals associated with the grant
applications, the disclosure of which Disorders and Stroke: Notice of Closed
applications, the disclosure of which would constitute a clearly unwarranted Meetings
would constitute a clearly unwarranted invasion of personal privacy.
invasion of personal privacy. Pursuant to section 10(d) of the
Name of Committee: National Heart, Lung, Federal Advisory Committee Act, as
Name of Committee: National Heart, Lung, and Blood Advisory Council.
and Blood Institute Special Emphasis Panel;
amended (5 U.S.C. App.), notice is
Date: February 10, 2016.
Lung Vascular Barrier Integrity PPG Review Open: 8:00 a.m. to 1:00 p.m.
hereby given of the following meetings.
Agenda: To discuss program policies and The meetings will be closed to the
Meeting.
Date: February 4, 2016. issues. public in accordance with the
Time: 10:00 a.m. to 3:00 p.m. Place: National Institutes of Health, Porter provisions set forth in sections
Agenda: To review and evaluate grant Neuroscience Research Center, Building 35A, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
applications. Convent Drive, Bethesda, MD 20892. as amended. The grant applications and
Place: National Institutes of Health, 6701 Closed: 1:00 p.m. to 4:30 p.m. the discussions could disclose
Rockledge Drive, Room 7196, Bethesda, MD Agenda: To review and evaluate grant confidential trade secrets or commercial
applications. property such as patentable material,
20892, (Telephone Conference Call).
Place: National Institutes of Health, Porter and personal information concerning
Contact Person: Charles Joyce, Ph.D., Neuroscience Research Center, Building 35A,
Scientific Review Officer, Office of Scientific individuals associated with the grant
Convent Drive, Bethesda, MD 20892.
Review/DERA, National Heart, Lung, and applications, the disclosure of which
Contact Person: Jodi Black, Ph.D., Acting
Blood Institute, 6701 Rockledge Drive, Room Director, Division of Extramural Research would constitute a clearly unwarranted
7196, Bethesda, MD 20892–7924, 301–435– Activities, National Heart, Lung, and Blood invasion of personal privacy.
0288 cjoyce@nhlbi.nih.gov. Institute, National Institutes of Health, 6701 Name of Committee: National Institute of
Rockledge Drive, Room 7104, Bethesda, MD Neurological Disorders and Stroke Special
(Catalogue of Federal Domestic Assistance
20892, (301) 435–0260, blackj@nih.gov. Emphasis Panel; NIH/NINDS BRAIN
Program Nos. 93.233, National Center for Initiative: X02 Teleconference.
Sleep Disorders Research; 93.837, Heart and Any interested person may file Date: January 14, 2016.
Vascular Diseases Research; 93.838, Lung written comments with the committee Time: 1:00 p.m. to 2:30 p.m.
Diseases Research; 93.839, Blood Diseases by forwarding the statement to the Agenda: To review and evaluate grant
and Resources Research, National Institutes Contact Person listed on this notice. The applications.
of Health, HHS) statement should include the name, Place: National Institutes of Health,
address, telephone number and when Neuroscience Center, 6001 Executive
ebenthall on DSK6SPTVN1PROD with NOTICES

Dated: January 5, 2016. Boulevard, Rockville, MD 20852 (Telephone
applicable, the business or professional
Michelle Trout, affiliation of the interested person. Conference Call).
Program Analyst, Office of Federal Advisory Contact Person: Ernest W. Lyons, Ph.D.,
In the interest of security, NIH has Scientific Review Administrator, Scientific
Committee Policy. instituted stringent procedures for Review Branch, NINDS/NIH/DHHS,
[FR Doc. 2016–00207 Filed 1–8–16; 8:45 am] entrance onto the NIH campus. All Neuroscience Center, 6001 Executive Blvd.,
BILLING CODE 4140–01–P visitor vehicles, including taxicabs, Suite 3208, MSC 9529, Bethesda, MD 20892–
hotel, and airport shuttles will be 9529, 301–496–4056, lyonse@ninds.nih.gov.

VerDate Sep<11>2014 21:33 Jan 14, 2016 Jkt 238001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 E:\FR\FM\11JAN1.SGM 11JAN1

Document Created: 2016-01-16 01:05:48
Document Modified: 2016-01-16 01:05:48

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Dates		The meeting will be held on February 2-3, 2016. The meeting times and agenda will be posted on the NVAC Web site at http:// www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/ as soon as they become available.
Contact		National Vaccine Program Office, U.S. Department of Health and Human Services, Room 715-H, Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: (202) 690-5566; email: [email protected]
FR Citation		81 FR 1194